What changed on the PTCE in 2026
PTCB started using a new PTCE content outline on January 6, 2026. If you studied with older material, here is what is different.
Removed from the exam
- Nonsterile compounding
- Sterile compounding
- Alligation calculations
- The separate narrow therapeutic index knowledge area (these drugs can still come up in other questions)
Added to the exam
- The Drug Supply Chain Security Act (DSCSA): product tracing, the transaction information and statement exchanged between trading partners, verification and handling suspect or illegitimate products
Still on the exam
- Pharmacy calculations, including dilutions and concentrations
- Controlled substance rules, recalls, REMS and other federal requirements
- Medication safety, error prevention and quality assurance
- Order entry: sig codes, days supply, NDC, lot and expiration numbers
New section weights
| Section (2026 outline) | Share of exam |
|---|---|
| Medications | 35% |
| Patient Safety and Quality Assurance | 23.75% |
| Order Entry and Processing | 22.5% |
| Federal Requirements | 18.75% |
Always check the current outline at ptcb.org before your exam.
How TechReady Rx handles the change
The question bank adds more than 300 questions written for the 2026 outline, including DSCSA. Compounding and alligation questions are kept out of practice sets and mock exams; Pro users can still review them as an optional extra set.